Annora Pharma Private Limited
Manufacturer / marketing-authorisation holder
Annora Pharma Private Limited — 14 products across 2 markets, 11 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Annora Pharma Private Limited — 14 productos en 2 mercados, 11 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Annora Pharma Private Limited —— 共 14 个产品,覆盖 2 个市场、11 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。
14 products · 2 markets · 11 brand names
14 productos · 2 mercados · 11 marcas
14 个产品 · 2 个市场 · 11 个品牌名
Products by country
US
Source: api.fda.gov
MX
Source: www.gob.mx
| Brand | Active ingredient(s) | Form |
|---|---|---|
| ANFALL | Brivaracetam | tablet |
| APOPLEX | 替格瑞洛 | tablet |
| BANGALI | 盐酸吉西他滨 | liquid |
| BEVAT | 枸橼酸托法替布 | tablet |
| CHAMUNDI | 盐酸伊伐布雷定 | tablet |
| GLYNDUR | 盐酸安非他酮 | tablet |
| LERGOTOL | 左炔诺孕酮 | tablet |
| LORAGAR | 富马酸喹硫平 | tablet |
| RUKARA | 奥卡西平 | tablet |
| VANSKEMED | 盐酸托莫西汀 | capsule |
| VERKORT | 琥珀酸索利那新 | tablet |